Search

Pharming Group NV

Geschlossen

1.22 -0.16

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.198

Max

1.225

Schlüsselkennzahlen

By Trading Economics

Einkommen

19M

4.7M

Verkäufe

14M

93M

EPS

0.006

Gewinnspanne

5.035

Angestellte

404

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+101.05% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

276M

893M

Vorheriger Eröffnungskurs

1.38

Vorheriger Schlusskurs

1.22

Pharming Group NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Okt. 2025, 23:25 UTC

Wichtige Markttreiber

Salesforce Rises on New FY30 Financial Targets

15. Okt. 2025, 18:52 UTC

Ergebnisse
Wichtige Markttreiber

Prologis Shares Gain on Raised Outlook, Data Center Growth

15. Okt. 2025, 18:30 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Software to Buy U.K.'s Tecvia Holding

15. Okt. 2025, 17:19 UTC

Akquisitionen, Fusionen, Übernahmen

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15. Okt. 2025, 17:11 UTC

Akquisitionen, Fusionen, Übernahmen

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15. Okt. 2025, 23:48 UTC

Market Talk

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15. Okt. 2025, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15. Okt. 2025, 22:37 UTC

Market Talk

Economic Stars Are Aligning for RBA -- Market Talk

15. Okt. 2025, 21:44 UTC

Ergebnisse

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15. Okt. 2025, 20:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

15. Okt. 2025, 20:44 UTC

Akquisitionen, Fusionen, Übernahmen

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15. Okt. 2025, 20:44 UTC

Akquisitionen, Fusionen, Übernahmen

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15. Okt. 2025, 20:43 UTC

Akquisitionen, Fusionen, Übernahmen

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15. Okt. 2025, 20:34 UTC

Ergebnisse

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15. Okt. 2025, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15. Okt. 2025, 20:17 UTC

Akquisitionen, Fusionen, Übernahmen

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15. Okt. 2025, 19:06 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15. Okt. 2025, 19:04 UTC

Market Talk

Oil Futures Post Back-to-Back Losses -- Market Talk

15. Okt. 2025, 18:46 UTC

Market Talk

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15. Okt. 2025, 18:23 UTC

Ergebnisse

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15. Okt. 2025, 17:37 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15. Okt. 2025, 17:34 UTC

Market Talk

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15. Okt. 2025, 16:57 UTC

Ergebnisse

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15. Okt. 2025, 16:51 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Doesn't Disclose Financial Details

15. Okt. 2025, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15. Okt. 2025, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15. Okt. 2025, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15. Okt. 2025, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15. Okt. 2025, 16:47 UTC

Akquisitionen, Fusionen, Übernahmen

EssilorLuxottica Buys Ikerian

15. Okt. 2025, 16:34 UTC

Market Talk

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Pharming Group NV Prognose

Kursziel

By TipRanks

101.05% Vorteil

12-Monats-Prognose

Durchschnitt 2.453 EUR  101.05%

Hoch 2.45 EUR

Tief 2.45 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pharming Group NV – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
help-icon Live chat